Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management.

Cancer Commun (Lond) · 2022 · PMC9759771 · PMID 36209487

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The future perspectives of CRISPR/Cas9‐based technology will be significant to workout new cancer biomarkers and novel genes which may be highly significant to target for cancer management.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.